Who has invested in Cadent Therapeutics?

Atlas Venture, Cowen are named among the investors backing Cadent Therapeutics.

Cadent Therapeutics Funding: $64M Raised, Series B (2020)

Cadent Therapeutics funding overview

Cadent Therapeutics is based in Cambridge, MA. Cadent Therapeutics has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2020. The round record for Cadent Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Atlas Venture, Cowen. 2 distinct backers are named across the disclosed rounds.

Cadent Therapeutics at a glance

Total raised: $64M
Latest round: Series B
Latest round date: April 2020
Headquarters: Cambridge, MA
Notable investors: Atlas Venture, Cowen

Frequently asked about Cadent Therapeutics funding

How much has Cadent Therapeutics raised?: Cadent Therapeutics has raised $64M in total disclosed funding across the rounds on record.
Who has invested in Cadent Therapeutics?: Atlas Venture, Cowen are named among the investors backing Cadent Therapeutics.
What was the latest Cadent Therapeutics funding round?: The most recent disclosed round is a Series B, announced in April 2020.
Where is Cadent Therapeutics based?: Cadent Therapeutics is based in Cambridge, MA.
When did Cadent Therapeutics last raise?: The last disclosed Cadent Therapeutics round closed in April 2020 at Series B.

Cadent Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Cadent Therapeutics Funding: $64M Raised, Series B (2020)

Cadent Therapeutics funding overview

Cadent Therapeutics at a glance

Frequently asked about Cadent Therapeutics funding

Companies related to Cadent Therapeutics (36)

Browse related funding lists (6)